SCHEDULE: American Century Boosts Visteon Stake to 8.2%

American Century Investment Management, Inc. and affiliates report an 8.2% passive beneficial ownership stake in Visteon Corporation.

Summary

• American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research collectively hold 2,222,551 shares of Visteon Corporation's Common Stock.
• This aggregate beneficial ownership represents 8.2% of Visteon Corporation's outstanding common stock.
• The reporting persons have sole voting power over 2,173,962 shares and sole dispositive power over 2,222,551 shares.
• The filing is an Amendment No. 2 to a Schedule 13G, indicating a passive investment position under Rule 13d-1(b).

Sentiment

Score: 7

Explanation: The filing indicates a significant passive stake by a reputable institutional investor, which is generally viewed as a positive signal of confidence in the company's value, without implying active intervention or control.

Positives

• The significant 8.2% passive stake held by American Century Investment Management, Inc. and its affiliates signals institutional confidence in Visteon Corporation's long-term prospects.

Stakeholder Impact

• Shareholders may perceive the substantial passive investment by a major institutional firm as a positive indicator of the company's stability and future potential.

Key Dates

Recommendation

The filing discloses a significant 8.2% passive stake by a major institutional investor, American Century Investment Management, Inc., and its affiliates. This indicates a vote of confidence in Visteon Corporation's long-term value without intent to influence control. While not a direct financial performance report, such a substantial institutional holding typically suggests stability and potential for appreciation, warranting a 'hold' recommendation for existing investors and a closer look for potential new investors.

Keywords

Visteon Corporation, American Century Investment Management, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Schedule 13G